Search

Bo Peng

Examiner (ID: 19836)

Most Active Art Unit
1648
Art Unit(s)
1648, CQIC, 4171, 4111
Total Applications
343
Issued Applications
135
Pending Applications
38
Abandoned Applications
170

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 363305 [patent_doc_number] => 07482115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Immobilisation and stabilisation of virus' [patent_app_type] => utility [patent_app_number] => 10/512635 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 5692 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/482/07482115.pdf [firstpage_image] =>[orig_patent_app_number] => 10512635 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/512635
Immobilisation and stabilisation of virus Apr 27, 2003 Issued
Array ( [id] => 6821574 [patent_doc_number] => 20030219735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Metabolically activated recombinant viral vectors and methods for their preparation and use' [patent_app_type] => new [patent_app_number] => 10/423507 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21950 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219735.pdf [firstpage_image] =>[orig_patent_app_number] => 10423507 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/423507
Metabolically activated recombinant viral vectors and methods for their preparation and use Apr 24, 2003 Issued
Array ( [id] => 6966414 [patent_doc_number] => 20050233311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Family of picornaviruses' [patent_app_type] => utility [patent_app_number] => 10/512392 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 1953 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233311.pdf [firstpage_image] =>[orig_patent_app_number] => 10512392 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/512392
Family of picornaviruses Apr 22, 2003 Abandoned
Array ( [id] => 4521093 [patent_doc_number] => 07951379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Hollow nanoparticle of NBsAg large protein for drug delivery' [patent_app_type] => utility [patent_app_number] => 10/509249 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 28 [patent_no_of_words] => 13829 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951379.pdf [firstpage_image] =>[orig_patent_app_number] => 10509249 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/509249
Hollow nanoparticle of NBsAg large protein for drug delivery Mar 25, 2003 Issued
Array ( [id] => 5742817 [patent_doc_number] => 20060088542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Imidazoquinoline adjuvants for vaccines' [patent_app_type] => utility [patent_app_number] => 10/508143 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25086 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088542.pdf [firstpage_image] =>[orig_patent_app_number] => 10508143 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/508143
Imidazoquinoline adjuvants for vaccines Mar 18, 2003 Abandoned
Array ( [id] => 7466485 [patent_doc_number] => 20040101957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol.nef and modifications' [patent_app_type] => new [patent_app_number] => 10/380641 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 145 [patent_figures_cnt] => 145 [patent_no_of_words] => 41205 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101957.pdf [firstpage_image] =>[orig_patent_app_number] => 10380641 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/380641
Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol.nef and modifications Mar 13, 2003 Abandoned
Array ( [id] => 7469577 [patent_doc_number] => 20040054139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Modification of hepatitis b core antigen' [patent_app_type] => new [patent_app_number] => 10/312045 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7886 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20040054139.pdf [firstpage_image] =>[orig_patent_app_number] => 10312045 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/312045
Modification of hepatitis b core antigen Mar 10, 2003 Abandoned
Array ( [id] => 7136080 [patent_doc_number] => 20050181064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith' [patent_app_type] => utility [patent_app_number] => 10/509247 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9472 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181064.pdf [firstpage_image] =>[orig_patent_app_number] => 10509247 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/509247
Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith Mar 4, 2003 Abandoned
Array ( [id] => 5873038 [patent_doc_number] => 20060165726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Remedies with the use of hollow protein nanoparticles presenting growth factor or the like' [patent_app_type] => utility [patent_app_number] => 10/509248 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5458 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165726.pdf [firstpage_image] =>[orig_patent_app_number] => 10509248 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/509248
Remedies with the use of hollow protein nanoparticles presenting growth factor or the like Mar 4, 2003 Abandoned
Array ( [id] => 6730241 [patent_doc_number] => 20030186431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Rabbit hemorrhagic disease vaccine and antigens' [patent_app_type] => new [patent_app_number] => 10/363503 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6478 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186431.pdf [firstpage_image] =>[orig_patent_app_number] => 10363503 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/363503
Rabbit hemorrhagic disease vaccine and antigens Mar 2, 2003 Abandoned
Array ( [id] => 5613886 [patent_doc_number] => 20060115814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Methods and compositions, relating to hiv gp41 antigens and other hiv envelope antigens' [patent_app_type] => utility [patent_app_number] => 10/506095 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25693 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115814.pdf [firstpage_image] =>[orig_patent_app_number] => 10506095 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/506095
Methods and compositions, relating to hiv gp41 antigens and other hiv envelope antigens Feb 25, 2003 Abandoned
Array ( [id] => 6821738 [patent_doc_number] => 20030219899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Mosaic adenoviral vectors' [patent_app_type] => new [patent_app_number] => 10/372615 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18247 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219899.pdf [firstpage_image] =>[orig_patent_app_number] => 10372615 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/372615
Mosaic adenoviral vectors Feb 20, 2003 Abandoned
Array ( [id] => 6678180 [patent_doc_number] => 20030228320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Retroviral immunotherapy' [patent_app_type] => new [patent_app_number] => 10/369256 [patent_app_country] => US [patent_app_date] => 2003-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13003 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228320.pdf [firstpage_image] =>[orig_patent_app_number] => 10369256 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/369256
Retroviral immunotherapy Feb 17, 2003 Abandoned
Array ( [id] => 6829266 [patent_doc_number] => 20030180324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use' [patent_app_type] => new [patent_app_number] => 10/364360 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7897 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180324.pdf [firstpage_image] =>[orig_patent_app_number] => 10364360 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/364360
Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use Feb 11, 2003 Abandoned
Array ( [id] => 6664542 [patent_doc_number] => 20030203868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Inhibition of pathogen replication by RNA interference' [patent_app_type] => new [patent_app_number] => 10/361161 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17559 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203868.pdf [firstpage_image] =>[orig_patent_app_number] => 10361161 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/361161
Inhibition of pathogen replication by RNA interference Feb 5, 2003 Abandoned
Array ( [id] => 7143645 [patent_doc_number] => 20050118567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Method for determining sensitivity to a bacteriophage' [patent_app_type] => utility [patent_app_number] => 10/498428 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12330 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118567.pdf [firstpage_image] =>[orig_patent_app_number] => 10498428 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/498428
Method for determining sensitivity to a bacteriophage Jan 22, 2003 Abandoned
Array ( [id] => 7152621 [patent_doc_number] => 20050025780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations' [patent_app_type] => utility [patent_app_number] => 10/501570 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10572 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20050025780.pdf [firstpage_image] =>[orig_patent_app_number] => 10501570 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/501570
Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations Jan 21, 2003 Abandoned
Array ( [id] => 6805351 [patent_doc_number] => 20030232745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection' [patent_app_type] => new [patent_app_number] => 10/328997 [patent_app_country] => US [patent_app_date] => 2002-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 37958 [patent_no_of_claims] => 206 [patent_no_of_ind_claims] => 59 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232745.pdf [firstpage_image] =>[orig_patent_app_number] => 10328997 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/328997
Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection Dec 23, 2002 Abandoned
Array ( [id] => 556179 [patent_doc_number] => 07157259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Murine lecithin-cholesterol acyltransferase protein' [patent_app_type] => utility [patent_app_number] => 10/323051 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 36062 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157259.pdf [firstpage_image] =>[orig_patent_app_number] => 10323051 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/323051
Murine lecithin-cholesterol acyltransferase protein Dec 17, 2002 Issued
Array ( [id] => 7437940 [patent_doc_number] => 20040002581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Peptides and use thereof in therapeutic agents against HIV infection' [patent_app_type] => new [patent_app_number] => 10/305133 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5533 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002581.pdf [firstpage_image] =>[orig_patent_app_number] => 10305133 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/305133
Peptides and use thereof in therapeutic agents against HIV infection Nov 26, 2002 Abandoned
Menu